IDXX vs NMAX · P/E 40, rev $2.36B vs rev $189.3M
IDEXX Laboratories Inc (IDXX) versus Newsmax, Inc. (NMAX) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Newsmax, Inc. (NMAX) is a broadcasting company listed on NYSE.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported NMAX revenue for 2025-12-31 was $189.3M. Net income was -$99.5M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. NMAX currently screens at market cap $1.01B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. NMAX currently screens at market cap $1.01B.
Not investment advice. Open the IDXX and NMAX stock pages for the full models.
Not investment advice.